Back to top
more

Bruker (BRKR)

(Real Time Quote from BATS)

$30.91 USD

30.91
44,215

+0.25 (0.82%)

Updated Aug 7, 2025 10:02 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Instruments - Scientific

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Bruker (BRKR) Meets Q2 Earnings Estimates

by Zacks Equity Research

Bruker (BRKR) delivered earnings and revenue surprises of 0% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

MedTech Stocks to Watch for Earnings on Aug 3

by Zacks Equity Research

MedTech players are likely to have benefited from the consistent opening of economies and sales contributions from high testing demand. Let's see how CRL, CVS, BRKR and NUVA fare this time.

Zacks Equity Research

Waters (WAT) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Waters (WAT) delivered earnings and revenue surprises of 4.56% and 1.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

PerkinElmer (PKI) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

PerkinElmer (PKI) delivered earnings and revenue surprises of 14.29% and 2.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Q2 Release

by Zacks Equity Research

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Bruker (BRKR) Debuts NMR Test for Research on Long COVID Risks

by Zacks Equity Research

Bruker's (BRKR) PhenoRisk PACS RuO will facilitate clinical research to combat the risks of Long COVID syndrome.

Zacks Equity Research

Bruker (BRKR) International Growth Strong Amid Competition

by Zacks Equity Research

Bruker (BRKR) Nano Group's microelectronics and semiconductor metrology tools continue to perform well with ongoing strength in bookings and backlog.

Zacks Equity Research

Zacks Industry Outlook Highlights Mettler-Toledo International, Waters and Bruker

by Zacks Equity Research

Mettler-Toledo International, Waters and Bruker have been highlighted in this Industry Outlook article.

Aniruddha Ganguly headshot

3 Stocks to Watch on Rising Demand for Scientific Instruments

by Aniruddha Ganguly

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), Waters (WAT) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand, as well as rising healthcare spending.

Zacks Equity Research

Bruker (BRKR) BSI & BEST Arms Drive Growth Amid Competition

by Zacks Equity Research

Bruker (BRKR) Nano Group's microelectronics and semiconductor metrology tools continue to perform well with ongoing strength in bookings and backlog.

Zacks Equity Research

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Bruker (BRKR) Debuts Module on Ultima Multiphoton Microscopes

by Zacks Equity Research

Bruker's (BRKR) NeuraLight 3D Ultra module offers revolutionary 3D holographic photostimulation to support neuroscience and optogenetics research applications.

Zacks Equity Research

Bruker (BRKR) to Advance 4D Proteomics With Latest Launch

by Zacks Equity Research

Bruker's (BRKR) timsTOF HT is enhanced for high-throughput, deep and unbiased plasma proteomics, and liquid biopsy biomarker research.

Zacks Equity Research

Why Is Bruker (BRKR) Up 6.3% Since Last Earnings Report?

by Zacks Equity Research

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Here's Why You Should Retain Bruker (BRKR) Stock for Now

by Zacks Equity Research

Investors are optimistic about Bruker (BRKR) on strength across the BSI and BEST businesses.

Zacks Equity Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Here's Why Bruker (BRKR) is a Strong Growth Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Up

by Zacks Equity Research

Revenue growth across the BSI and BEST businesses drove Bruker's (BRKR) first-quarter 2022 revenues.

Zacks Equity Research

Bruker (BRKR) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Bruker (BRKR) delivered earnings and revenue surprises of 19.51% and 3.90%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Waters (WAT) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Waters (WAT) delivered earnings and revenue surprises of 20.69% and 9.12%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Bruker (BRKR) Unveils New Imaging Tools for Cancer Research

by Zacks Equity Research

Bruker's (BRKR) latest innovation for cancer research is likely to strengthen the company's opportunities in proteomics and spatial biology.

Zacks Equity Research

Bruker's (BRKR) Buyout to Expand Mass Spectrometry Prospects

by Zacks Equity Research

Bruker's (BRKR) acquisition of IonSense will reach the DART ionization technology to a wider customer base.

Zacks Equity Research

Bruker (BRKR) to Support Biopharma Industries With New Buyout

by Zacks Equity Research

Bruker's (BRKR) recent buyout strengthens the company as a key software and solutions provider for small molecule, biologics and new drug modalities pharma companies.

Zacks Equity Research

Here's Why You Should Add Bruker (BRKR) Stock to Your Kitty

by Zacks Equity Research

Bruker's (BRKR) Nano Group microelectronics and semiconductor metrology tools continue to perform well on ongoing strength in bookings and backlog.